SummaryHot = near-term stock price gain potential, not just product developments, lab breakthroughs, corporate acquisitions, financing deals, trial progresses etc.
Only opinions; not even “just the facts, m’aam”. But opinions expressed by folks who need to know, willing to put their money at risk, based on what they know.
Maybe even better, ones who are willing to pay up for price-change risk […]
Follow the Money with Investorideas.com; Biotech Stocks
Ideas get bigger when you share them…
Point Roberts, WA – NEW YORK, NY – February 11, 2015 (www.investorideas.com newswire) Investorideas.com, a global news source covering leading sectors including biotech, medical technology and life sciences stocks updates its biotech stocks directory for investors following the sector. There have been several IPOs recently and there are […]
Follow the Money with Investorideas.com; Biotech Stocks
Ideas get bigger when you share them…
Point Roberts, WA – NEW YORK, NY – February 11, 2015 (www.investorideas.com newswire) Investorideas.com, a global news source covering leading sectors including biotech, medical technology and life sciences stocks updates its biotech stocks directory for investors following the sector. There have been several IPOs recently and there are […]
Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.Copyright ©2015 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.
Excerpt from:
5 Biotech Stocks to Short | InvestorPlace
[…]
OK, listen up – it’s time to “buy the dip.”I’m talking about the biotech dip that just happened. Here’s the deal:A leading biotech company just issued some news that spooked some jittery investors. The stock took a dive, taking the entire sector down a peg or two.But this is just a temporary blip, and it’s handing you a golden chance […]
View the original here –
Deutsche Bank Loves These Small-Cap Biotech Stocks – PTC …
[…]
Biotech is big, and the industry has been big for quite some time.As a matter of fact, biotechnology has been the second-best performing industry over the last two years.Biotech stocks obviously come in all different shapes and sizes. Some investors like the small-caps, others prefer the middle of the road mid-caps.However, at the end of the day, the big biotechs […]
They say good things come in threes. If so, biotech companies could be in for not just another year of outperformance, but another decade. The first era of biotech was a building phase, when companies created their first blockbuster drugs. The second, current one, has resulted in a four-year rally that reflects the sector’s transition from a cluster of one-hit […]
The biotech sector has started 2015 with the announcement of several deals. Both Kite Pharma (KITE – Snapshot Report) and Isis Pharmaceuticals (ISIS – Analyst Report) saw their share prices increasing on collaboration agreements with major companies. Meanwhile, Alkermes (ALKS – Analyst Report) has also started the year on a positive note with encouraging pipeline data.Recap of the Week’s Most […]
SummaryBiotech stocks should outperform the market in 2015. However the biotech sector is linked to healthcare fundamentals like government pricing policy.
The industry is better financed than any time in its history driving innovation and new product growth. The appetite for M&A and IPOs will continue.
Biopharmaceutical stocks defy traditional analysis and have been a safe haven from global economic news.
2015: Another […]
